Literature DB >> 21278485

Phosphorylation of EZH2 by CDK1 and CDK2: a possible regulatory mechanism of transmission of the H3K27me3 epigenetic mark through cell divisions.

Xianzhuo Zeng1, Shuai Chen, Haojie Huang.   

Abstract

Histone H3 lysine 27 trimethylation (H3K27me3) catalyzed by the enzymatic subunit EZH2 in the Polycomb repressive complex 2 (PRC2) is essential for cells to 'memorize' gene expression patterns through cell divisions and plays an important role in establishing and maintaining cell identity during development. However, how the epigenetic mark is inherited through cell generations remains poorly understood. Recently, we and others demonstrate that CDK1 and CDK2 phosphorylate EZH2 at threonine 350 (T350) and that T350 phosphorylation is important for the binding of EZH2 to PRC2 recruiters, such as noncoding RNAs (ncRNAs) HOTAIR and XIST, and for the effective recruitment of PRC2 to EZH2 target loci in cells. These findings imply that phosphorylation of EZH2 by CDK1 and CDK2 may provide cells a mechanism that enhances EZH2 function during S and G2 phases of the cell cycle, thereby ensuring K27me3 on de novo synthesized H3 incorporated in nascent nucleosomes before sister chromosomes are divided into two daughter cells. Additionally, a potential role of T350 phosphorylation of EZH2 in differing EZH2 from its homolog EZH1 in catalyzing H3K27me3 as well as the interplay between phosphorylation at T350 and other residues (e.g. phosphorylation by p38 at threonine 372 (T372)) in governing EZH2 activity in proliferating versus non-dividing cells are also discussed. Together, CDK phosphorylation of EZH2 at T350 may represent a key regulatory mechanism of EZH2 function that is essential for the maintenance of H3K27me3 marks through cell divisions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21278485      PMCID: PMC3174000          DOI: 10.4161/cc.10.4.14850

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  35 in total

Review 1.  The key to development: interpreting the histone code?

Authors:  Raphael Margueron; Patrick Trojer; Danny Reinberg
Journal:  Curr Opin Genet Dev       Date:  2005-04       Impact factor: 5.578

2.  Control of developmental regulators by Polycomb in human embryonic stem cells.

Authors:  Tong Ihn Lee; Richard G Jenner; Laurie A Boyer; Matthew G Guenther; Stuart S Levine; Roshan M Kumar; Brett Chevalier; Sarah E Johnstone; Megan F Cole; Kyo-ichi Isono; Haruhiko Koseki; Takuya Fuchikami; Kuniya Abe; Heather L Murray; Jacob P Zucker; Bingbing Yuan; George W Bell; Elizabeth Herbolsheimer; Nancy M Hannett; Kaiming Sun; Duncan T Odom; Arie P Otte; Thomas L Volkert; David P Bartel; Douglas A Melton; David K Gifford; Rudolf Jaenisch; Richard A Young
Journal:  Cell       Date:  2006-04-21       Impact factor: 41.582

3.  Suz12 binds to silenced regions of the genome in a cell-type-specific manner.

Authors:  Sharon L Squazzo; Henriette O'Geen; Vitalina M Komashko; Sheryl R Krig; Victor X Jin; Sung-wook Jang; Raphael Margueron; Danny Reinberg; Roland Green; Peggy J Farnham
Journal:  Genome Res       Date:  2006-06-02       Impact factor: 9.043

Review 4.  Polycomb silencers control cell fate, development and cancer.

Authors:  Anke Sparmann; Maarten van Lohuizen
Journal:  Nat Rev Cancer       Date:  2006-11       Impact factor: 60.716

Review 5.  Chromatin modifications and their function.

Authors:  Tony Kouzarides
Journal:  Cell       Date:  2007-02-23       Impact factor: 41.582

Review 6.  The role of chromatin during transcription.

Authors:  Bing Li; Michael Carey; Jerry L Workman
Journal:  Cell       Date:  2007-02-23       Impact factor: 41.582

7.  Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs.

Authors:  John L Rinn; Michael Kertesz; Jordon K Wang; Sharon L Squazzo; Xiao Xu; Samantha A Brugmann; L Henry Goodnough; Jill A Helms; Peggy J Farnham; Eran Segal; Howard Y Chang
Journal:  Cell       Date:  2007-06-29       Impact factor: 41.582

8.  A quantitative atlas of mitotic phosphorylation.

Authors:  Noah Dephoure; Chunshui Zhou; Judit Villén; Sean A Beausoleil; Corey E Bakalarski; Stephen J Elledge; Steven P Gygi
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-31       Impact factor: 11.205

9.  Molecular and functional mapping of EED motifs required for PRC2-dependent histone methylation.

Authors:  Nathan D Montgomery; Della Yee; Stephanie A Montgomery; Terry Magnuson
Journal:  J Mol Biol       Date:  2007-10-22       Impact factor: 5.469

10.  Different EZH2-containing complexes target methylation of histone H1 or nucleosomal histone H3.

Authors:  Andrei Kuzmichev; Thomas Jenuwein; Paul Tempst; Danny Reinberg
Journal:  Mol Cell       Date:  2004-04-23       Impact factor: 17.970

View more
  32 in total

1.  Androgen receptor serine 81 phosphorylation mediates chromatin binding and transcriptional activation.

Authors:  Shaoyong Chen; Sarah Gulla; Changmeng Cai; Steven P Balk
Journal:  J Biol Chem       Date:  2012-01-24       Impact factor: 5.157

2.  EZH2 and ALDH1 expression in ductal carcinoma in situ: complex association with recurrence and progression to invasive breast cancer.

Authors:  Erik S Knudsen; Ornella Dervishaj; Celina G Kleer; Thomas Pajak; Gordon F Schwartz; Agnieszka K Witkiewicz
Journal:  Cell Cycle       Date:  2013-06-06       Impact factor: 4.534

Review 3.  Long non-coding RNA HOTAIR in carcinogenesis and metastasis.

Authors:  Jinsong Zhang; Peijing Zhang; Li Wang; Hai-long Piao; Li Ma
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2013-10-27       Impact factor: 3.848

Review 4.  Regulation and role of post-translational modifications of enhancer of zeste homologue 2 in cancer development.

Authors:  Haiqi Lu; Guangliang Li; Chenyi Zhou; Wei Jin; Xiaoling Qian; Zhuo Wang; Hongming Pan; Hongchuan Jin; Xian Wang
Journal:  Am J Cancer Res       Date:  2016-12-01       Impact factor: 6.166

Review 5.  Timing is everything: the when and how of environmentally induced changes in the epigenome of animals.

Authors:  Christopher Faulk; Dana C Dolinoy
Journal:  Epigenetics       Date:  2011-07-01       Impact factor: 4.528

6.  Histone modifiers in cancer: friends or foes?

Authors:  Idan Cohen; Elżbieta Poręba; Kinga Kamieniarz; Robert Schneider
Journal:  Genes Cancer       Date:  2011-06

7.  Phosphorylation-mediated EZH2 inactivation promotes drug resistance in multiple myeloma.

Authors:  Jiro Kikuchi; Daisuke Koyama; Taeko Wada; Tohru Izumi; Peter O Hofgaard; Bjarne Bogen; Yusuke Furukawa
Journal:  J Clin Invest       Date:  2015-10-26       Impact factor: 14.808

Review 8.  Inner workings and regulatory inputs that control Polycomb repressive complex 2.

Authors:  M Maggie O'Meara; Jeffrey A Simon
Journal:  Chromosoma       Date:  2012-02-19       Impact factor: 4.316

9.  The CDK4/6-EZH2 pathway is a potential therapeutic target for psoriasis.

Authors:  Anne Müller; Antje Dickmanns; Claudia Resch; Knut Schäkel; Stephan Hailfinger; Matthias Dobbelstein; Klaus Schulze-Osthoff; Daniela Kramer
Journal:  J Clin Invest       Date:  2020-11-02       Impact factor: 14.808

10.  JNK and STAT3 signaling pathways converge on Akt-mediated phosphorylation of EZH2 in bronchial epithelial cells induced by arsenic.

Authors:  Bailing Chen; Jia Liu; Qingshan Chang; Kevin Beezhold; Yongju Lu; Fei Chen
Journal:  Cell Cycle       Date:  2012-12-19       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.